Ulrich A.K. Betz, Paul Czodrowski, Christina Esdar, Carl Deutsch, Norbert Beier, Dirk Finsinger, Bertram Cezanne, Klaus Urbahns and Margarita Wucherer-Plietker Pages 77 - 81 ( 5 )
The pharmaceutical industry heavily relies on external sources to supplement its internal R&D activities and fill its product pipelines. Outsourcing of workpackages, in-licensing of development projects, collaborations with academic research centers or biotech companies and hiring of consultants are classic approaches towards this goal. Here we describe a new open innovation approach, termed “fluctuating open teams (FLOT)” that combines synergistically internal and external talent for a drug discovery project. The approach is compared to other open innovation options and constitutes an ideal way to boost creativity and new ideas for project teams that hit a roadblock.
Creativity, crowd sourcing, diversity, drug discovery, open innovation, project teams, research and development.
Merck KGaA, Frankfurterstraße 250, D-64293 Darmstadt, Germany.